nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproterone acetate—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.215	1	CrCrCtD
Cyproterone acetate—NR3C1—Methylprednisolone—multiple sclerosis	0.114	0.193	CbGbCtD
Cyproterone acetate—NR3C1—Triamcinolone—multiple sclerosis	0.0863	0.147	CbGbCtD
Cyproterone acetate—CYP19A1—Betamethasone—multiple sclerosis	0.0816	0.139	CbGbCtD
Cyproterone acetate—NR3C1—Betamethasone—multiple sclerosis	0.0741	0.126	CbGbCtD
Cyproterone acetate—NR3C1—Prednisolone—multiple sclerosis	0.0731	0.124	CbGbCtD
Cyproterone acetate—NR3C1—Prednisone—multiple sclerosis	0.069	0.117	CbGbCtD
Cyproterone acetate—CYP19A1—Dexamethasone—multiple sclerosis	0.0475	0.0806	CbGbCtD
Cyproterone acetate—NR3C1—Dexamethasone—multiple sclerosis	0.0431	0.0732	CbGbCtD
Cyproterone acetate—Ethynodiol—PGR—multiple sclerosis	0.00192	0.464	CrCbGaD
Cyproterone acetate—Megestrol acetate—PGR—multiple sclerosis	0.00141	0.339	CrCbGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP27B1—multiple sclerosis	0.00119	0.0377	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—CYP24A1—multiple sclerosis	0.00119	0.0377	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.00102	0.0325	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—HNRNPA1—multiple sclerosis	0.00091	0.0288	CbGpPWpGaD
Cyproterone acetate—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.000819	0.197	CrCbGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000817	0.0259	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000737	0.0234	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000737	0.0234	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000728	0.0231	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000728	0.0231	CbGpPWpGaD
Cyproterone acetate—AR—Coregulation of Androgen receptor activity—ZMIZ1—multiple sclerosis	0.000719	0.0228	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.00062	0.0196	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000598	0.0189	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000598	0.0189	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.000588	0.0186	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.000588	0.0186	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—PGR—multiple sclerosis	0.000578	0.0183	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—PGR—multiple sclerosis	0.000571	0.0181	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—ZMIZ1—multiple sclerosis	0.000532	0.0168	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.000506	0.016	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—BDNF—multiple sclerosis	0.000466	0.0148	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000457	0.0145	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	0.000439	0.0139	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptors—VDR—multiple sclerosis	0.000404	0.0128	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000399	0.0126	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	0.000388	0.0123	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Endogenous sterols—POMC—multiple sclerosis	0.000357	0.0113	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.000348	0.011	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	0.000347	0.011	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000339	0.0108	CbGpPWpGaD
Cyproterone acetate—AR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000319	0.0101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP24A1—multiple sclerosis	0.000318	0.0101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Biological oxidations—CYP27B1—multiple sclerosis	0.000318	0.0101	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000313	0.00992	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000313	0.00992	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	0.000307	0.00971	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—ZMIZ1—multiple sclerosis	0.0003	0.00949	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	0.000291	0.00922	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000278	0.0088	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—multiple sclerosis	0.000268	0.00848	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000262	0.00829	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000257	0.00816	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000257	0.00815	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000257	0.00815	CbGpPWpGaD
Cyproterone acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	0.000242	0.00768	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000221	0.00699	CbGpPWpGaD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000215	0.0068	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	0.000211	0.00668	CbGpPWpGaD
Cyproterone acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	0.000208	0.00658	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	0.000198	0.00629	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000195	0.00618	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—CD4—multiple sclerosis	0.000188	0.00597	CbGpPWpGaD
Cyproterone acetate—AR—Nongenotropic Androgen signaling—MAPK1—multiple sclerosis	0.000185	0.00586	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	0.000183	0.0058	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	0.000178	0.00564	CbGpPWpGaD
Cyproterone acetate—CYP19A1—FSH signaling pathway—MAPK1—multiple sclerosis	0.000178	0.00563	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	0.000176	0.00557	CbGpPWpGaD
Cyproterone acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.000171	0.00541	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	0.000167	0.0053	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000166	0.00526	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	0.000163	0.00516	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	0.000161	0.00511	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	0.000157	0.00497	CbGpPWpGaD
Cyproterone acetate—AR—Notch-mediated HES/HEY network—STAT3—multiple sclerosis	0.000146	0.00462	CbGpPWpGaD
Cyproterone acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	0.000142	0.00449	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.000141	0.00447	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000134	0.00426	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000133	0.00421	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL10—multiple sclerosis	0.000127	0.00402	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	0.000126	0.00401	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—ZNF746—multiple sclerosis	0.000126	0.00399	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	0.000125	0.00395	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000122	0.00386	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000122	0.00386	CbGpPWpGaD
Cyproterone acetate—Angiopathy—Betamethasone—multiple sclerosis	0.000117	0.000727	CcSEcCtD
Cyproterone acetate—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000116	0.000723	CcSEcCtD
Cyproterone acetate—Fatigue—Mitoxantrone—multiple sclerosis	0.000115	0.000717	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—PTBP1—multiple sclerosis	0.000115	0.00365	CbGpPWpGaD
Cyproterone acetate—Pancreatitis—Methotrexate—multiple sclerosis	0.000115	0.000714	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000115	0.000713	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000115	0.000712	CcSEcCtD
Cyproterone acetate—Constipation—Mitoxantrone—multiple sclerosis	0.000114	0.000711	CcSEcCtD
Cyproterone acetate—Alopecia—Betamethasone—multiple sclerosis	0.000114	0.000708	CcSEcCtD
Cyproterone acetate—Alopecia—Dexamethasone—multiple sclerosis	0.000114	0.000708	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	0.000114	0.00361	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Azathioprine—multiple sclerosis	0.000113	0.000704	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisolone—multiple sclerosis	0.000113	0.000703	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	0.000113	0.00358	CbGpPWpGaD
Cyproterone acetate—Haemoglobin—Prednisone—multiple sclerosis	0.000113	0.000701	CcSEcCtD
Cyproterone acetate—Haemorrhage—Prednisone—multiple sclerosis	0.000112	0.000698	CcSEcCtD
Cyproterone acetate—Malaise—Triamcinolone—multiple sclerosis	0.000112	0.000693	CcSEcCtD
Cyproterone acetate—Malaise—Methylprednisolone—multiple sclerosis	0.000111	0.000692	CcSEcCtD
Cyproterone acetate—Syncope—Triamcinolone—multiple sclerosis	0.000111	0.000689	CcSEcCtD
Cyproterone acetate—Syncope—Methylprednisolone—multiple sclerosis	0.000111	0.000688	CcSEcCtD
Cyproterone acetate—Connective tissue disorder—Prednisone—multiple sclerosis	0.00011	0.000686	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00011	0.000685	CcSEcCtD
Cyproterone acetate—Oedema—Prednisolone—multiple sclerosis	0.00011	0.000682	CcSEcCtD
Cyproterone acetate—Dizziness—Azathioprine—multiple sclerosis	0.00011	0.00068	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000109	0.00068	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000109	0.000676	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000109	0.000674	CcSEcCtD
Cyproterone acetate—Shock—Prednisolone—multiple sclerosis	0.000108	0.000671	CcSEcCtD
Cyproterone acetate—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000108	0.000671	CcSEcCtD
Cyproterone acetate—Cough—Triamcinolone—multiple sclerosis	0.000108	0.000671	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	0.000108	0.00341	CbGpPWpGaD
Cyproterone acetate—Tachycardia—Prednisolone—multiple sclerosis	0.000107	0.000666	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—multiple sclerosis	0.000107	0.0034	CbGpPWpGaD
Cyproterone acetate—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000107	0.000665	CcSEcCtD
Cyproterone acetate—Urticaria—Mitoxantrone—multiple sclerosis	0.000106	0.000661	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000106	0.00066	CcSEcCtD
Cyproterone acetate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000106	0.000657	CcSEcCtD
Cyproterone acetate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000106	0.000657	CcSEcCtD
Cyproterone acetate—Vomiting—Azathioprine—multiple sclerosis	0.000105	0.000654	CcSEcCtD
Cyproterone acetate—Eye disorder—Prednisone—multiple sclerosis	0.000105	0.000652	CcSEcCtD
Cyproterone acetate—Rash—Azathioprine—multiple sclerosis	0.000104	0.000649	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000104	0.000649	CcSEcCtD
Cyproterone acetate—Dermatitis—Azathioprine—multiple sclerosis	0.000104	0.000648	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000104	0.000647	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000104	0.000647	CcSEcCtD
Cyproterone acetate—Discomfort—Triamcinolone—multiple sclerosis	0.000104	0.000647	CcSEcCtD
Cyproterone acetate—Discomfort—Methylprednisolone—multiple sclerosis	0.000104	0.000645	CcSEcCtD
Cyproterone acetate—Headache—Azathioprine—multiple sclerosis	0.000104	0.000644	CcSEcCtD
Cyproterone acetate—Renal failure—Methotrexate—multiple sclerosis	0.000103	0.000639	CcSEcCtD
Cyproterone acetate—Angiopathy—Prednisone—multiple sclerosis	0.000102	0.000633	CcSEcCtD
Cyproterone acetate—Immune system disorder—Prednisone—multiple sclerosis	0.000101	0.00063	CcSEcCtD
Cyproterone acetate—Malaise—Betamethasone—multiple sclerosis	0.000101	0.000629	CcSEcCtD
Cyproterone acetate—Malaise—Dexamethasone—multiple sclerosis	0.000101	0.000629	CcSEcCtD
Cyproterone acetate—Oedema—Triamcinolone—multiple sclerosis	0.000101	0.000627	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000101	0.0032	CbGpPWpGaD
Cyproterone acetate—Syncope—Betamethasone—multiple sclerosis	0.000101	0.000626	CcSEcCtD
Cyproterone acetate—Syncope—Dexamethasone—multiple sclerosis	0.000101	0.000626	CcSEcCtD
Cyproterone acetate—Sweating—Methotrexate—multiple sclerosis	0.0001	0.000623	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—FAS—multiple sclerosis	9.99e-05	0.00317	CbGpPWpGaD
Cyproterone acetate—Haematuria—Methotrexate—multiple sclerosis	9.97e-05	0.000619	CcSEcCtD
Cyproterone acetate—Shock—Triamcinolone—multiple sclerosis	9.94e-05	0.000617	CcSEcCtD
Cyproterone acetate—Alopecia—Prednisone—multiple sclerosis	9.93e-05	0.000617	CcSEcCtD
Cyproterone acetate—Shock—Methylprednisolone—multiple sclerosis	9.92e-05	0.000616	CcSEcCtD
Cyproterone acetate—Hepatobiliary disease—Methotrexate—multiple sclerosis	9.89e-05	0.000614	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methylprednisolone—multiple sclerosis	9.88e-05	0.000614	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Dexamethasone—multiple sclerosis	9.87e-05	0.000613	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Betamethasone—multiple sclerosis	9.87e-05	0.000613	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Mitoxantrone—multiple sclerosis	9.86e-05	0.000613	CcSEcCtD
Cyproterone acetate—Tachycardia—Triamcinolone—multiple sclerosis	9.86e-05	0.000612	CcSEcCtD
Cyproterone acetate—Mental disorder—Prednisone—multiple sclerosis	9.84e-05	0.000611	CcSEcCtD
Cyproterone acetate—Nausea—Azathioprine—multiple sclerosis	9.84e-05	0.000611	CcSEcCtD
Cyproterone acetate—Tachycardia—Methylprednisolone—multiple sclerosis	9.84e-05	0.000611	CcSEcCtD
Cyproterone acetate—Skin disorder—Methylprednisolone—multiple sclerosis	9.79e-05	0.000608	CcSEcCtD
Cyproterone acetate—Malnutrition—Prednisone—multiple sclerosis	9.78e-05	0.000607	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Triamcinolone—multiple sclerosis	9.76e-05	0.000607	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	9.74e-05	0.000605	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	9.68e-05	0.00307	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	9.63e-05	0.00305	CbGpPWpGaD
Cyproterone acetate—Asthenia—Mitoxantrone—multiple sclerosis	9.61e-05	0.000597	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	9.56e-05	0.00303	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—ZNF746—multiple sclerosis	9.56e-05	0.00303	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	9.48e-05	0.003	CbGpPWpGaD
Cyproterone acetate—Discomfort—Betamethasone—multiple sclerosis	9.45e-05	0.000587	CcSEcCtD
Cyproterone acetate—Discomfort—Dexamethasone—multiple sclerosis	9.45e-05	0.000587	CcSEcCtD
Cyproterone acetate—Haemoglobin—Methotrexate—multiple sclerosis	9.44e-05	0.000586	CcSEcCtD
Cyproterone acetate—Hypotension—Methylprednisolone—multiple sclerosis	9.42e-05	0.000585	CcSEcCtD
Cyproterone acetate—Haemorrhage—Methotrexate—multiple sclerosis	9.39e-05	0.000583	CcSEcCtD
Cyproterone acetate—Hepatitis—Methotrexate—multiple sclerosis	9.39e-05	0.000583	CcSEcCtD
Cyproterone acetate—Oedema—Dexamethasone—multiple sclerosis	9.16e-05	0.000569	CcSEcCtD
Cyproterone acetate—Oedema—Betamethasone—multiple sclerosis	9.16e-05	0.000569	CcSEcCtD
Cyproterone acetate—Diarrhoea—Mitoxantrone—multiple sclerosis	9.16e-05	0.000569	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Prednisone—multiple sclerosis	9.07e-05	0.000564	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Prednisolone—multiple sclerosis	9.05e-05	0.000562	CcSEcCtD
Cyproterone acetate—Visual impairment—Methotrexate—multiple sclerosis	9.05e-05	0.000562	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	9.05e-05	0.00287	CbGpPWpGaD
Cyproterone acetate—Anaemia—Prednisone—multiple sclerosis	9.04e-05	0.000561	CcSEcCtD
Cyproterone acetate—Shock—Dexamethasone—multiple sclerosis	9.02e-05	0.00056	CcSEcCtD
Cyproterone acetate—Shock—Betamethasone—multiple sclerosis	9.02e-05	0.00056	CcSEcCtD
Cyproterone acetate—Dyspnoea—Triamcinolone—multiple sclerosis	9.01e-05	0.000559	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Betamethasone—multiple sclerosis	8.99e-05	0.000558	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Dexamethasone—multiple sclerosis	8.99e-05	0.000558	CcSEcCtD
Cyproterone acetate—Agitation—Prednisone—multiple sclerosis	8.99e-05	0.000558	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Betamethasone—multiple sclerosis	8.97e-05	0.000557	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Dexamethasone—multiple sclerosis	8.97e-05	0.000557	CcSEcCtD
Cyproterone acetate—Tachycardia—Dexamethasone—multiple sclerosis	8.94e-05	0.000556	CcSEcCtD
Cyproterone acetate—Tachycardia—Betamethasone—multiple sclerosis	8.94e-05	0.000556	CcSEcCtD
Cyproterone acetate—Dyspepsia—Triamcinolone—multiple sclerosis	8.89e-05	0.000552	CcSEcCtD
Cyproterone acetate—Erythema multiforme—Methotrexate—multiple sclerosis	8.88e-05	0.000551	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methylprednisolone—multiple sclerosis	8.87e-05	0.000551	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Betamethasone—multiple sclerosis	8.86e-05	0.00055	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Dexamethasone—multiple sclerosis	8.86e-05	0.00055	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—multiple sclerosis	8.85e-05	0.00281	CbGpPWpGaD
Cyproterone acetate—Malaise—Prednisone—multiple sclerosis	8.82e-05	0.000548	CcSEcCtD
Cyproterone acetate—Eye disorder—Methotrexate—multiple sclerosis	8.77e-05	0.000545	CcSEcCtD
Cyproterone acetate—Syncope—Prednisone—multiple sclerosis	8.77e-05	0.000545	CcSEcCtD
Cyproterone acetate—AR—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	8.77e-05	0.00278	CbGpPWpGaD
Cyproterone acetate—AR—Androgen receptor signaling pathway—STAT3—multiple sclerosis	8.75e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PTBP1—multiple sclerosis	8.74e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—Anorexia—Betamethasone—multiple sclerosis	8.74e-05	0.000543	CcSEcCtD
Cyproterone acetate—Anorexia—Dexamethasone—multiple sclerosis	8.74e-05	0.000543	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—HNRNPA1—multiple sclerosis	8.73e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—U2AF2—multiple sclerosis	8.73e-05	0.00277	CbGpPWpGaD
Cyproterone acetate—Urticaria—Prednisolone—multiple sclerosis	8.73e-05	0.000542	CcSEcCtD
Cyproterone acetate—Fatigue—Triamcinolone—multiple sclerosis	8.71e-05	0.000541	CcSEcCtD
Cyproterone acetate—Fatigue—Methylprednisolone—multiple sclerosis	8.69e-05	0.00054	CcSEcCtD
Cyproterone acetate—Loss of consciousness—Prednisone—multiple sclerosis	8.6e-05	0.000534	CcSEcCtD
Cyproterone acetate—Hypotension—Dexamethasone—multiple sclerosis	8.56e-05	0.000532	CcSEcCtD
Cyproterone acetate—Hypotension—Betamethasone—multiple sclerosis	8.56e-05	0.000532	CcSEcCtD
Cyproterone acetate—Angiopathy—Methotrexate—multiple sclerosis	8.52e-05	0.000529	CcSEcCtD
Cyproterone acetate—Vomiting—Mitoxantrone—multiple sclerosis	8.51e-05	0.000529	CcSEcCtD
Cyproterone acetate—Immune system disorder—Methotrexate—multiple sclerosis	8.48e-05	0.000527	CcSEcCtD
Cyproterone acetate—Mediastinal disorder—Methotrexate—multiple sclerosis	8.46e-05	0.000526	CcSEcCtD
Cyproterone acetate—Rash—Mitoxantrone—multiple sclerosis	8.44e-05	0.000524	CcSEcCtD
Cyproterone acetate—Dermatitis—Mitoxantrone—multiple sclerosis	8.43e-05	0.000524	CcSEcCtD
Cyproterone acetate—Chills—Methotrexate—multiple sclerosis	8.42e-05	0.000523	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	8.42e-05	0.00267	CbGpPWpGaD
Cyproterone acetate—Headache—Mitoxantrone—multiple sclerosis	8.39e-05	0.000521	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Triamcinolone—multiple sclerosis	8.32e-05	0.000517	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Methylprednisolone—multiple sclerosis	8.31e-05	0.000516	CcSEcCtD
Cyproterone acetate—Alopecia—Methotrexate—multiple sclerosis	8.3e-05	0.000515	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	8.27e-05	0.000514	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	8.24e-05	0.000512	CcSEcCtD
Cyproterone acetate—Discomfort—Prednisone—multiple sclerosis	8.23e-05	0.000511	CcSEcCtD
Cyproterone acetate—Mental disorder—Methotrexate—multiple sclerosis	8.23e-05	0.000511	CcSEcCtD
Cyproterone acetate—Malnutrition—Methotrexate—multiple sclerosis	8.17e-05	0.000508	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisolone—multiple sclerosis	8.09e-05	0.000503	CcSEcCtD
Cyproterone acetate—Dyspepsia—Dexamethasone—multiple sclerosis	8.07e-05	0.000501	CcSEcCtD
Cyproterone acetate—Dyspepsia—Betamethasone—multiple sclerosis	8.07e-05	0.000501	CcSEcCtD
Cyproterone acetate—Urticaria—Triamcinolone—multiple sclerosis	8.02e-05	0.000498	CcSEcCtD
Cyproterone acetate—Urticaria—Methylprednisolone—multiple sclerosis	8.01e-05	0.000497	CcSEcCtD
Cyproterone acetate—Body temperature increased—Triamcinolone—multiple sclerosis	7.98e-05	0.000496	CcSEcCtD
Cyproterone acetate—Oedema—Prednisone—multiple sclerosis	7.98e-05	0.000496	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methylprednisolone—multiple sclerosis	7.97e-05	0.000495	CcSEcCtD
Cyproterone acetate—Decreased appetite—Betamethasone—multiple sclerosis	7.97e-05	0.000495	CcSEcCtD
Cyproterone acetate—Decreased appetite—Dexamethasone—multiple sclerosis	7.97e-05	0.000495	CcSEcCtD
Cyproterone acetate—Nausea—Mitoxantrone—multiple sclerosis	7.95e-05	0.000494	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	7.91e-05	0.000492	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Betamethasone—multiple sclerosis	7.91e-05	0.000492	CcSEcCtD
Cyproterone acetate—Fatigue—Betamethasone—multiple sclerosis	7.9e-05	0.000491	CcSEcCtD
Cyproterone acetate—Fatigue—Dexamethasone—multiple sclerosis	7.9e-05	0.000491	CcSEcCtD
Cyproterone acetate—AR—Generic Transcription Pathway—PGR—multiple sclerosis	7.89e-05	0.0025	CbGpPWpGaD
Cyproterone acetate—Shock—Prednisone—multiple sclerosis	7.85e-05	0.000488	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Prednisone—multiple sclerosis	7.83e-05	0.000486	CcSEcCtD
Cyproterone acetate—Tachycardia—Prednisone—multiple sclerosis	7.79e-05	0.000484	CcSEcCtD
Cyproterone acetate—Skin disorder—Prednisone—multiple sclerosis	7.75e-05	0.000482	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Prednisone—multiple sclerosis	7.72e-05	0.000479	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—SRM—multiple sclerosis	7.71e-05	0.00244	CbGpPWpGaD
Cyproterone acetate—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	7.63e-05	0.00242	CbGpPWpGaD
Cyproterone acetate—Anorexia—Prednisone—multiple sclerosis	7.61e-05	0.000473	CcSEcCtD
Cyproterone acetate—Ill-defined disorder—Methotrexate—multiple sclerosis	7.58e-05	0.000471	CcSEcCtD
Cyproterone acetate—Anaemia—Methotrexate—multiple sclerosis	7.55e-05	0.000469	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Betamethasone—multiple sclerosis	7.55e-05	0.000469	CcSEcCtD
Cyproterone acetate—Feeling abnormal—Dexamethasone—multiple sclerosis	7.55e-05	0.000469	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Betamethasone—multiple sclerosis	7.49e-05	0.000466	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	7.49e-05	0.000466	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	7.47e-05	0.00237	CbGpPWpGaD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	7.46e-05	0.00236	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Triamcinolone—multiple sclerosis	7.44e-05	0.000462	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Methylprednisolone—multiple sclerosis	7.43e-05	0.000461	CcSEcCtD
Cyproterone acetate—Malaise—Methotrexate—multiple sclerosis	7.37e-05	0.000458	CcSEcCtD
Cyproterone acetate—Leukopenia—Methotrexate—multiple sclerosis	7.32e-05	0.000454	CcSEcCtD
Cyproterone acetate—Urticaria—Betamethasone—multiple sclerosis	7.28e-05	0.000452	CcSEcCtD
Cyproterone acetate—Urticaria—Dexamethasone—multiple sclerosis	7.28e-05	0.000452	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisolone—multiple sclerosis	7.26e-05	0.000451	CcSEcCtD
Cyproterone acetate—Asthenia—Triamcinolone—multiple sclerosis	7.25e-05	0.00045	CcSEcCtD
Cyproterone acetate—Abdominal pain—Dexamethasone—multiple sclerosis	7.25e-05	0.00045	CcSEcCtD
Cyproterone acetate—Abdominal pain—Betamethasone—multiple sclerosis	7.25e-05	0.00045	CcSEcCtD
Cyproterone acetate—Body temperature increased—Dexamethasone—multiple sclerosis	7.25e-05	0.00045	CcSEcCtD
Cyproterone acetate—Body temperature increased—Betamethasone—multiple sclerosis	7.25e-05	0.00045	CcSEcCtD
Cyproterone acetate—Asthenia—Methylprednisolone—multiple sclerosis	7.23e-05	0.000449	CcSEcCtD
Cyproterone acetate—Pruritus—Triamcinolone—multiple sclerosis	7.15e-05	0.000444	CcSEcCtD
Cyproterone acetate—CYP19A1—Biological oxidations—POMC—multiple sclerosis	7.14e-05	0.00226	CbGpPWpGaD
Cyproterone acetate—Cough—Methotrexate—multiple sclerosis	7.13e-05	0.000443	CcSEcCtD
Cyproterone acetate—Pruritus—Methylprednisolone—multiple sclerosis	7.13e-05	0.000443	CcSEcCtD
Cyproterone acetate—Dyspepsia—Prednisone—multiple sclerosis	7.03e-05	0.000436	CcSEcCtD
Cyproterone acetate—Decreased appetite—Prednisone—multiple sclerosis	6.94e-05	0.000431	CcSEcCtD
Cyproterone acetate—Rash—Prednisolone—multiple sclerosis	6.93e-05	0.00043	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisolone—multiple sclerosis	6.92e-05	0.00043	CcSEcCtD
Cyproterone acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	6.91e-05	0.000429	CcSEcCtD
Cyproterone acetate—AR—Gene Expression—ZFP36L1—multiple sclerosis	6.9e-05	0.00219	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Methylprednisolone—multiple sclerosis	6.9e-05	0.000428	CcSEcCtD
Cyproterone acetate—Fatigue—Prednisone—multiple sclerosis	6.88e-05	0.000427	CcSEcCtD
Cyproterone acetate—Headache—Prednisolone—multiple sclerosis	6.88e-05	0.000427	CcSEcCtD
Cyproterone acetate—Discomfort—Methotrexate—multiple sclerosis	6.87e-05	0.000427	CcSEcCtD
Cyproterone acetate—Constipation—Prednisone—multiple sclerosis	6.83e-05	0.000424	CcSEcCtD
Cyproterone acetate—Dizziness—Triamcinolone—multiple sclerosis	6.68e-05	0.000415	CcSEcCtD
Cyproterone acetate—Dizziness—Methylprednisolone—multiple sclerosis	6.66e-05	0.000414	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	6.66e-05	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	6.65e-05	0.00211	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—U2AF2—multiple sclerosis	6.62e-05	0.0021	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	6.62e-05	0.0021	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Prednisone—multiple sclerosis	6.58e-05	0.000409	CcSEcCtD
Cyproterone acetate—Asthenia—Dexamethasone—multiple sclerosis	6.58e-05	0.000408	CcSEcCtD
Cyproterone acetate—Asthenia—Betamethasone—multiple sclerosis	6.58e-05	0.000408	CcSEcCtD
Cyproterone acetate—Nervous system disorder—Methotrexate—multiple sclerosis	6.54e-05	0.000406	CcSEcCtD
Cyproterone acetate—Thrombocytopenia—Methotrexate—multiple sclerosis	6.53e-05	0.000406	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Prednisone—multiple sclerosis	6.53e-05	0.000405	CcSEcCtD
Cyproterone acetate—Nausea—Prednisolone—multiple sclerosis	6.52e-05	0.000405	CcSEcCtD
Cyproterone acetate—Pruritus—Betamethasone—multiple sclerosis	6.48e-05	0.000403	CcSEcCtD
Cyproterone acetate—Pruritus—Dexamethasone—multiple sclerosis	6.48e-05	0.000403	CcSEcCtD
Cyproterone acetate—Skin disorder—Methotrexate—multiple sclerosis	6.48e-05	0.000402	CcSEcCtD
Cyproterone acetate—Hyperhidrosis—Methotrexate—multiple sclerosis	6.45e-05	0.000401	CcSEcCtD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	6.44e-05	0.00204	CbGpPWpGaD
Cyproterone acetate—Vomiting—Triamcinolone—multiple sclerosis	6.42e-05	0.000399	CcSEcCtD
Cyproterone acetate—Vomiting—Methylprednisolone—multiple sclerosis	6.41e-05	0.000398	CcSEcCtD
Cyproterone acetate—Rash—Triamcinolone—multiple sclerosis	6.37e-05	0.000396	CcSEcCtD
Cyproterone acetate—Dermatitis—Triamcinolone—multiple sclerosis	6.36e-05	0.000395	CcSEcCtD
Cyproterone acetate—Anorexia—Methotrexate—multiple sclerosis	6.36e-05	0.000395	CcSEcCtD
Cyproterone acetate—Rash—Methylprednisolone—multiple sclerosis	6.35e-05	0.000395	CcSEcCtD
Cyproterone acetate—Dermatitis—Methylprednisolone—multiple sclerosis	6.35e-05	0.000394	CcSEcCtD
Cyproterone acetate—Urticaria—Prednisone—multiple sclerosis	6.34e-05	0.000394	CcSEcCtD
Cyproterone acetate—Headache—Triamcinolone—multiple sclerosis	6.33e-05	0.000393	CcSEcCtD
Cyproterone acetate—Headache—Methylprednisolone—multiple sclerosis	6.31e-05	0.000392	CcSEcCtD
Cyproterone acetate—Abdominal pain—Prednisone—multiple sclerosis	6.31e-05	0.000392	CcSEcCtD
Cyproterone acetate—Body temperature increased—Prednisone—multiple sclerosis	6.31e-05	0.000392	CcSEcCtD
Cyproterone acetate—Diarrhoea—Dexamethasone—multiple sclerosis	6.27e-05	0.00039	CcSEcCtD
Cyproterone acetate—Diarrhoea—Betamethasone—multiple sclerosis	6.27e-05	0.00039	CcSEcCtD
Cyproterone acetate—Hypotension—Methotrexate—multiple sclerosis	6.23e-05	0.000387	CcSEcCtD
Cyproterone acetate—Dizziness—Dexamethasone—multiple sclerosis	6.06e-05	0.000376	CcSEcCtD
Cyproterone acetate—Dizziness—Betamethasone—multiple sclerosis	6.06e-05	0.000376	CcSEcCtD
Cyproterone acetate—Nausea—Triamcinolone—multiple sclerosis	6e-05	0.000373	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	5.99e-05	0.0019	CbGpPWpGaD
Cyproterone acetate—Nausea—Methylprednisolone—multiple sclerosis	5.99e-05	0.000372	CcSEcCtD
Cyproterone acetate—Dyspnoea—Methotrexate—multiple sclerosis	5.95e-05	0.000369	CcSEcCtD
Cyproterone acetate—Hypersensitivity—Prednisone—multiple sclerosis	5.88e-05	0.000365	CcSEcCtD
Cyproterone acetate—Dyspepsia—Methotrexate—multiple sclerosis	5.87e-05	0.000365	CcSEcCtD
Cyproterone acetate—Vomiting—Dexamethasone—multiple sclerosis	5.83e-05	0.000362	CcSEcCtD
Cyproterone acetate—Vomiting—Betamethasone—multiple sclerosis	5.83e-05	0.000362	CcSEcCtD
Cyproterone acetate—Decreased appetite—Methotrexate—multiple sclerosis	5.8e-05	0.00036	CcSEcCtD
Cyproterone acetate—Rash—Dexamethasone—multiple sclerosis	5.78e-05	0.000359	CcSEcCtD
Cyproterone acetate—Rash—Betamethasone—multiple sclerosis	5.78e-05	0.000359	CcSEcCtD
Cyproterone acetate—Dermatitis—Dexamethasone—multiple sclerosis	5.77e-05	0.000359	CcSEcCtD
Cyproterone acetate—Dermatitis—Betamethasone—multiple sclerosis	5.77e-05	0.000359	CcSEcCtD
Cyproterone acetate—Gastrointestinal disorder—Methotrexate—multiple sclerosis	5.76e-05	0.000358	CcSEcCtD
Cyproterone acetate—Fatigue—Methotrexate—multiple sclerosis	5.75e-05	0.000357	CcSEcCtD
Cyproterone acetate—Headache—Dexamethasone—multiple sclerosis	5.74e-05	0.000357	CcSEcCtD
Cyproterone acetate—Headache—Betamethasone—multiple sclerosis	5.74e-05	0.000357	CcSEcCtD
Cyproterone acetate—Asthenia—Prednisone—multiple sclerosis	5.73e-05	0.000356	CcSEcCtD
Cyproterone acetate—Pruritus—Prednisone—multiple sclerosis	5.65e-05	0.000351	CcSEcCtD
Cyproterone acetate—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	5.62e-05	0.00178	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—VDR—multiple sclerosis	5.52e-05	0.00175	CbGpPWpGaD
Cyproterone acetate—Feeling abnormal—Methotrexate—multiple sclerosis	5.5e-05	0.000341	CcSEcCtD
Cyproterone acetate—Diarrhoea—Prednisone—multiple sclerosis	5.46e-05	0.000339	CcSEcCtD
Cyproterone acetate—Gastrointestinal pain—Methotrexate—multiple sclerosis	5.45e-05	0.000339	CcSEcCtD
Cyproterone acetate—Nausea—Dexamethasone—multiple sclerosis	5.44e-05	0.000338	CcSEcCtD
Cyproterone acetate—Nausea—Betamethasone—multiple sclerosis	5.44e-05	0.000338	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—CYP27B1—multiple sclerosis	5.43e-05	0.00172	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—CYP24A1—multiple sclerosis	5.43e-05	0.00172	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PABPC1—multiple sclerosis	5.35e-05	0.0017	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	5.33e-05	0.00169	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.31e-05	0.00168	CbGpPWpGaD
Cyproterone acetate—Urticaria—Methotrexate—multiple sclerosis	5.3e-05	0.000329	CcSEcCtD
Cyproterone acetate—Dizziness—Prednisone—multiple sclerosis	5.28e-05	0.000328	CcSEcCtD
Cyproterone acetate—Body temperature increased—Methotrexate—multiple sclerosis	5.27e-05	0.000328	CcSEcCtD
Cyproterone acetate—Abdominal pain—Methotrexate—multiple sclerosis	5.27e-05	0.000328	CcSEcCtD
Cyproterone acetate—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	5.24e-05	0.00166	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	5.21e-05	0.00165	CbGpPWpGaD
Cyproterone acetate—Vomiting—Prednisone—multiple sclerosis	5.07e-05	0.000315	CcSEcCtD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.05e-05	0.0016	CbGpPWpGaD
Cyproterone acetate—Rash—Prednisone—multiple sclerosis	5.03e-05	0.000313	CcSEcCtD
Cyproterone acetate—Dermatitis—Prednisone—multiple sclerosis	5.03e-05	0.000312	CcSEcCtD
Cyproterone acetate—Headache—Prednisone—multiple sclerosis	5e-05	0.000311	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—GPC5—multiple sclerosis	4.97e-05	0.00157	CbGpPWpGaD
Cyproterone acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	4.95e-05	0.00157	CbGpPWpGaD
Cyproterone acetate—Hypersensitivity—Methotrexate—multiple sclerosis	4.91e-05	0.000305	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—STAT3—multiple sclerosis	4.9e-05	0.00155	CbGpPWpGaD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—TNF—multiple sclerosis	4.83e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—RPL5—multiple sclerosis	4.83e-05	0.00153	CbGpPWpGaD
Cyproterone acetate—Asthenia—Methotrexate—multiple sclerosis	4.79e-05	0.000297	CcSEcCtD
Cyproterone acetate—Nausea—Prednisone—multiple sclerosis	4.74e-05	0.000294	CcSEcCtD
Cyproterone acetate—Pruritus—Methotrexate—multiple sclerosis	4.72e-05	0.000293	CcSEcCtD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MYC—multiple sclerosis	4.58e-05	0.00145	CbGpPWpGaD
Cyproterone acetate—Diarrhoea—Methotrexate—multiple sclerosis	4.56e-05	0.000284	CcSEcCtD
Cyproterone acetate—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	4.54e-05	0.00144	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—multiple sclerosis	4.48e-05	0.00142	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	4.41e-05	0.0014	CbGpPWpGaD
Cyproterone acetate—Dizziness—Methotrexate—multiple sclerosis	4.41e-05	0.000274	CcSEcCtD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	4.4e-05	0.00139	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	4.32e-05	0.00137	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—TNF—multiple sclerosis	4.24e-05	0.00134	CbGpPWpGaD
Cyproterone acetate—Vomiting—Methotrexate—multiple sclerosis	4.24e-05	0.000263	CcSEcCtD
Cyproterone acetate—Rash—Methotrexate—multiple sclerosis	4.21e-05	0.000261	CcSEcCtD
Cyproterone acetate—Dermatitis—Methotrexate—multiple sclerosis	4.2e-05	0.000261	CcSEcCtD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	4.18e-05	0.00133	CbGpPWpGaD
Cyproterone acetate—Headache—Methotrexate—multiple sclerosis	4.18e-05	0.00026	CcSEcCtD
Cyproterone acetate—CYP19A1—Metabolism—RRM1—multiple sclerosis	4.12e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—AR—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	4.11e-05	0.0013	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PABPC1—multiple sclerosis	4.06e-05	0.00129	CbGpPWpGaD
Cyproterone acetate—Nausea—Methotrexate—multiple sclerosis	3.96e-05	0.000246	CcSEcCtD
Cyproterone acetate—AR—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3.9e-05	0.00124	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—PGR—multiple sclerosis	3.8e-05	0.0012	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.67e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—RPL5—multiple sclerosis	3.66e-05	0.00116	CbGpPWpGaD
Cyproterone acetate—NR3C1—Adipogenesis—IL6—multiple sclerosis	3.42e-05	0.00108	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.19e-05	0.00101	CbGpPWpGaD
Cyproterone acetate—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.96e-05	0.000938	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—PGR—multiple sclerosis	2.88e-05	0.000914	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.74e-05	0.000869	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—VDR—multiple sclerosis	2.66e-05	0.000841	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.5e-05	0.000792	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—BCHE—multiple sclerosis	2.36e-05	0.000749	CbGpPWpGaD
Cyproterone acetate—AR—Generic Transcription Pathway—MYC—multiple sclerosis	2.19e-05	0.000695	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—VDR—multiple sclerosis	2.01e-05	0.000638	CbGpPWpGaD
Cyproterone acetate—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	1.66e-05	0.000527	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—APOE—multiple sclerosis	1.42e-05	0.000451	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—POMC—multiple sclerosis	1.22e-05	0.000387	CbGpPWpGaD
Cyproterone acetate—CYP19A1—Metabolism—ALB—multiple sclerosis	1.11e-05	0.000353	CbGpPWpGaD
Cyproterone acetate—AR—Gene Expression—MYC—multiple sclerosis	1.06e-05	0.000334	CbGpPWpGaD
Cyproterone acetate—NR3C1—Gene Expression—MYC—multiple sclerosis	8.01e-06	0.000254	CbGpPWpGaD
